Reconstructive surgery for chronic lymphedema: a viable option, but.

Area of Science:

• Lymphedema Management
• Surgical Innovation
• Microsurgery

Background:

• Chronic lymphedema often necessitates advanced treatment beyond conservative measures.
• Complex decongestive therapy (CDT) is a standard but may be insufficient for some patients.
• Reconstructive lymphatic surgery offers potential for improved outcomes in refractory lymphedema.

Purpose of the Study:

• To evaluate the long-term efficacy of reconstructive lymphatic surgery for chronic lymphedema.
• To compare lymphovenous anastomotic surgery (LVAS) and free lymph node transplant surgery (FLTS) in a retrospective analysis.
• To identify factors influencing surgical success in lymphedema treatment.

Main Methods:

• Retrospective analysis of 32 patients with chronic lymphedema unresponsive to at least one year of CDT.
• Surgical interventions included lymphovenous anastomotic surgery (LVAS) and free lymph node transplant surgery (FLTS).
• Patient outcomes were assessed over a four-year follow-up period, focusing on sustained improvement and compliance.

Main Results:

• Six patients (three from LVAS, three from FLTS) with secondary lymphedema (clinical stage II) maintained initial improvement over four years.
• Both LVAS and FLTS demonstrated efficacy, particularly in early-stage secondary lymphedema.
• Patient compliance with postoperative CDT was crucial for durable results.

Conclusions:

• Reconstructive lymphatic surgery (LVAS and FLTS) is more effective for secondary lymphedema in early stages.
• Sustained patient compliance with CDT post-surgery is the most critical factor for long-term success.
• FLTS carries donor site risks and may have a more limited role than LVAS; further research is needed.